Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05830721 · ClinicalTrials.gov registry record · NA

Continuous Compartment Pressure Monitoring for Compartment Syndrome in VA-ECMO Patients

A NA study of Extracorporeal Membrane Oxygenation Complication and Compartment Syndrome of Leg, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT05830721: Recruiting NA study of Extracorporeal Membrane Oxygenation Complication and Compartment Syndrome of Leg, sponsored by Johns Hopkins University.

NCT05830721 is a NA study of Extracorporeal Membrane Oxygenation Complication and Compartment Syndrome of Leg that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 6 participants, below the 837-participant average among 8 other Extracorporeal Membrane Oxygenation Complication trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05830721, a NA study of Extracorporeal Membrane Oxygenation Complication and Compartment Syndrome of Leg, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

Acute compartment syndrome (ACS) is a surgical emergency that can develop in patients on extracorporeal membrane oxygenation (ECMO). ACS is a type of limb ischemia, which means that the limb, such as the arm or leg, loses blood flow. Patients on ECMO can develop this condition for many reasons, but most commonly from the ECMO procedure itself. This most commonly involves the leg. Key symptoms of ACS include severe pain, loss of pulses, loss of feeling, and inability to move the limb. However, because patients on ECMO are often sedated, ACS is difficult to diagnose as patients can not report symptoms. As a result, the only available tool for diagnosing ACS may be measurement of pressures in the limb. This is normally done with a needle-device, which is inserted into the leg for a single measurement. However, a recently developed device, called the MY01 Continuous Compartment Pressure Monitor, allows for continuous pressure readings instead of a single measurement. Multiple measurements may allow for much greater accuracy in diagnosing ACS, which may result in faster time to surgery and potentially save more limbs than single measurements. This device may also be less invasive than an older method of continuous pressure measuring, which uses a needle and tubing that is 14-gauge in size. Therefore, this study aims to compare 3 different types of methods for diagnosing ACS in patients on ECMO, which are 1) Standard of Care, 2) Standard of Care and MY01, and 3)Standard of Care and 14-gauge slit catheter.

Primary Outcome

Diagnosis of compartment syndrome

Interventions

  • OTHER Standard of Care
  • DEVICE MY01 + Standard of Care
  • DEVICE 14-Gauge Slit Catheter + Standard of Care

Study Locations (1)

Maryland

  • The Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2024-01-02
Est. Completion 2027-12
Phase NA
Johns Hopkins University

1,448 total trials

What NCT05830721 shows while recruiting

NCT05830721 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 837-participant average among 8 other Extracorporeal Membrane Oxygenation Complication trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Extracorporeal Membrane Oxygenation Complication appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care is the first listed.

NCT05830721 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT05830721 about?

NCT05830721 is a clinical study titled "Continuous Compartment Pressure Monitoring for Compartment Syndrome in VA-ECMO Patients". Acute compartment syndrome (ACS) is a surgical emergency that can develop in patients on extracorporeal membrane oxygenation (ECMO). ACS is a type of limb ischemia, which means that the limb, such as the arm or leg, loses blood flow. Patients on ECMO can develop this condition for many reasons, but ...

What is the current status of trial NCT05830721?

This trial is currently recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2024-01-02. Estimated completion is 2027-12.

What conditions does trial NCT05830721 study?

This clinical trial studies the following conditions: Extracorporeal Membrane Oxygenation Complication, Compartment Syndrome of Leg, Limb Ischemia, Limb Ischemia, Critical.

What interventions are being tested in trial NCT05830721?

The interventions under investigation include: Standard of Care (OTHER), MY01 + Standard of Care (DEVICE), 14-Gauge Slit Catheter + Standard of Care (DEVICE).

Who is sponsoring clinical trial NCT05830721?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05830721 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Extracorporeal Membrane Oxygenation Complication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05830721's enrollment target sits among peer trials

6 9th of 8 the lowest of 8 other Extracorporeal Membrane Oxygenation Complication trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Extracorporeal Membrane Oxygenation Complication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05830721, the US trial registry maintained by the National Library of Medicine. NCT05830721 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.